All Comments by Anne Fagan
- Cerebrospinal Fluid Neurogranin Correlates with Markers of Neurodegeneration
- Correlation of Specific Amyloid-β Oligomers With Tau in Cerebrospinal Fluid From Cognitively Normal Older Adults.
- Cerebrospinal fluid levels of β-amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia.
- Amyloid-β associated volume loss occurs only in the presence of phospho-tau.
- In the Blood: What Can Plasma Aβ Tell Us About Alzheimer’s?
- Novel CSF biomarkers for Alzheimer's disease and mild cognitive impairment.
- A Blood Test for AD?
- Molecular markers of early Parkinson's disease based on gene expression in blood.
- CSF Biomarkers—Maybe You Can See the Forest for the Trees
- Statin Use and Alzheimer Disease: A Tale of Two Methodologies?
- Atorvastatin, Vaccine Trial Data Published
- Gene delivery of human apolipoprotein E alters brain Abeta burden in a mouse model of Alzheimer's disease.